Compare Abeona Therapeutics Inc (ABEO) vs Carvana Co (CVNA) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs Carvana Co — how do they compare? Abeona Therapeutics Inc trades at $6.74 (market cap $373.32M), while Carvana Co trades at $64.98 (market cap $48.34B). The key difference: Carvana Co is far larger — about 129.5× Abeona Therapeutics Inc's market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, Carvana Co nearer its low. Which is the better fit depends on your goals.
| ABEO | CVNA | |
|---|---|---|
Market Cap | $373.32M | $48.34B |
Sector | Health | Consumer Cyclical |
52-Week High | $7.23 | $95.69 |
52-Week Low | $4.17 | $56.27 |
Enterprise Value | $228.22M | $50.99B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
Carvana (CVNA) trades at $67.47, down 1.63% on the day, with a bullish technical signal and strong fundamental growth. Revenue surged to $20.32B in 2025, with net income reaching $1.41B, though Q2 2026 earnings are pending. Recent corporate actions include stock splits, and expansion news includes same-day delivery in Milwaukee.
The outlook is positive with analyst consensus at Buy and a $93.92 price target, but risks include high debt levels and competitive pressures. Upside potential exists from operational efficiency and market expansion, yet volatility from used-car market softness remains a concern for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Carvana Co
Carvana Co is an e-commerce platform for buying and selling used cars. The company derives revenue from used vehicle sales, wholesale vehicle sales and other sales and revenues. The other sales and revenues include sales of loans originated and sold in securitization transactions or to financing partners, commissions received on VSCs and sales of GAP waiver coverage.
Read more on CVNA →
